You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent breast cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

HER2-positive Recurrent/Metastatic Breast Cancer Trial (Inetetamab, pyrotinib, chemo)

Not yet recruiting
  • HER2-positive Recurrent/Metastatic Breast Cancer
  • Inetetamab, pyrotinib, chemotherapy
  • (no location specified)
Nov 16, 2022

Breast Cancer Female, Breast Tumor Female Trial in United States (SV-BR-1-GM, INCMGA00012, Low dose cyclophosphamide)

Recruiting
  • Breast Cancer
  • +3 more
  • SV-BR-1-GM
  • +3 more
  • Newport Beach, California
  • +9 more
Dec 8, 2022

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

Prognostic Significance of HER-2 Status Discordance Between

Completed
  • Breast Cancer
  • no intervention
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 19, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Breast Cancer Recurrent Trial

Not yet recruiting
  • Breast Cancer Recurrent
    • (no location specified)
    Jan 12, 2023

    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

    Terminated
    Has Results
    • Estrogen Receptor-positive Breast Cancer
    • +7 more
    • Atlanta, Georgia
    • +2 more
    Mar 10, 2022

    Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer Trial (Ribociclib, Fulvestrant,

    Not yet recruiting
    • Locoregional Recurrence
    • +2 more
    • (no location specified)
    Jul 18, 2022

    Circulating miRNAs.

    Completed
    • Breast Cancer
    • +2 more
      • Cork, Ireland
      • +6 more
      Jan 4, 2022

      Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)

      Active, not recruiting
      • Metastatic Breast Cancer
      • Recurrent Breast Cancer
      • Boston, Massachusetts
      • +2 more
      Mar 21, 2022

      Metastatic Breast Cancer Trial in Shanghai (Sitravatinib, Tislelizumab, Nab-paclitaxel)

      Recruiting
      • Metastatic Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer
      Jul 31, 2022

      Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Belgium, Denmark, Spain (ModraDoc006/r)

      Completed
      • Metastatic Breast Cancer
      • Recurrent Breast Cancer
      • Brussels, Belgium
      • +3 more
      Oct 18, 2021

      Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

      Completed
      • Male Breast Cancer
      • +7 more
      • propranolol hydrochloride
      • Correlative Studies
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Dec 4, 2022

      Triple-negative Breast Cancer Trial in Changsha, Nanjing (SKB264, KL-A167)

      Not yet recruiting
      • Triple-negative Breast Cancer
      • Changsha, Hunan, China
      • +1 more
      Jun 30, 2022

      HER2 Positive Breast Cancer Trial in Ireland (Copanlisib, Trastuzumab)

      Completed
      • HER2 Positive Breast Cancer
      • Cork, Ireland
      • +4 more
      Jul 25, 2022

      Comprehensive Gene Sequencing in Guiding Treatment

      Completed
      • Recurrent Breast Cancer
      • +7 more
      • cytology specimen collection procedure
      • laboratory biomarker analysis
      • Columbus, Ohio
        Arthur G. James Cancer Hospital and Solove Research Institute at
      Oct 21, 2021

      Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)

      Recruiting
      • Locally Recurrent/Metastatic Triple Negative Breast Cancer
      • external beam radiation therapy
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Aug 8, 2022

      Breast Cancer, Breast Cancer Recurrent Trial (rPBI)

      Not yet recruiting
      • Breast Cancer
      • Breast Cancer Recurrent
      • rPBI
      • (no location specified)
      Oct 21, 2022

      Fasting, Breast Cancer, Survivorship Trial in Boston (Fasting)

      Completed
      • Fasting
      • +3 more
      • Fasting
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Jul 18, 2022

      Metastatic Breast Cancer, Recurrent Ovarian Carcinoma Trial in Salt Lake City, Fairfax (Ribociclib, Belinostat)

      Recruiting
      • Metastatic Breast Cancer
      • Recurrent Ovarian Carcinoma
      • Salt Lake City, Utah
      • +1 more
      May 3, 2022

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

      Recruiting
      • BRCA1 Gene Mutation
      • +19 more
      • Laboratory Biomarker Analysis
      • Pembrolizumab
      • New Brunswick, New Jersey
      • +1 more
      Nov 16, 2022

      Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

      Recruiting
      • Advanced Breast Carcinoma
      • +17 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Blood and Tumor Samples From Advanced or Metastatic Estrogen

      Active, not recruiting
      • Advanced Breast Carcinoma
      • +8 more
      • Biopsy
      • +2 more
      • Scottsdale, Arizona
      • +2 more
      Jan 3, 2023